Common use of Stability Data Clause in Contracts

Stability Data. Without limiting Santarus’ obligations in Section 5.3.1, GSK shall have the right and be responsible for generating at its expense any stability data necessary to expeditiously file for and obtain Marketing Authorizations throughout the GSK Territory to the extent such data is beyond the current or scheduled Santarus stability programs. In the event that Santarus wishes to use any of this stability data in Regulatory Filings for Licensed Products outside of the GSK Territory and Territory under the Distribution Agreement, excluding uses by Santarus as required by Applicable Law, the Parties shall negotiate in good faith for appropriate compensation by Santarus for the use of such stability data, such compensation to be determined by reference to the anticipated commercial value respectively to GSK and Santarus of using such data.

Appears in 2 contracts

Sources: License Agreement, License Agreement (Salix Pharmaceuticals LTD)